We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,327 results
  1. Pregnancy, folic acid, and antiseizure medication

    Background

    Although some antiseizure medications (ASMs) are teratogenic, most people with epilepsy need treatment in pregnancy. The risk of ASM...

    Marte-Helene Bjørk, Håkon Vegrim, ... Elisabeth Synnøve Nilsen Husebye in Clinical Epileptology
    Article Open access 03 July 2023
  2. Antiseizure Drugs and Movement Disorders

    The relationship between antiseizure drugs and movement disorders is complex and not adequately reviewed so far. Antiseizure drugs as a treatment for...

    Michel Sáenz-Farret, Marina A. J. Tijssen, ... Alfonso Fasano in CNS Drugs
    Article 21 July 2022
  3. Neurobehavioral Outcomes of Children with Antenatal Exposure to Antiseizure Medications

    Objectives

    To evaluate the effect of antiepileptic medications prescribed to mothers during pregnancy on the development and behavior of children.

    ...
    Deepa Bhaskaran, Sanjeev Thomas, Liss Maria Scaria in Indian Journal of Pediatrics
    Article 08 June 2024
  4. Long-term antiseizure medication use in patients after meningioma resection: identifying predictors for successful weaning and failures

    Objective

    To define risk factors for meningioma-related seizures and predictors of successful weaning of antiseizure medications following meningioma...

    Erin M. Ellis, Michael R. Drumm, ... Jessica W. Templer in Journal of Neuro-Oncology
    Article 24 October 2023
  5. Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment

    The use of direct oral anticoagulants (DOACs) is increasing because of their superior efficacy and safety compared with vitamin K antagonists....

    Rachel Goldstein, Aviya R. Jacobs, ... Mordechai Muszkat in CNS Drugs
    Article 03 March 2023
  6. Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis

    Background and Objective

    Drug–drug interactions between direct oral anticoagulants (DOAC) and antiseizure medications via the cytochrome P450 (CYP) or...

    Bonaventure Y. Ip, Ho Ko, ... Thomas W. Leung in CNS Drugs
    Article Open access 24 November 2022
  7. Synergistic effects of vagus nerve stimulation and antiseizure medication

    Introduction

    Vagus nerve stimulation (VNS) is an effective, non-pharmacological therapy for epileptic seizures. Until now, favorable combinations of...

    Yaroslav Winter, Katharina Sandner, ... Sergiu Groppa in Journal of Neurology
    Article Open access 27 June 2023
  8. Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review

    Objective

    The objective of this study was to assess the efficacy and tolerability of intranasal midazolam (in-MDZ) administration for antiseizure...

    Tolga D. Dittrich, Dominik Vock, ... Raoul Sutter in Neurocritical Care
    Article Open access 05 April 2024
  9. Antiseizure Medication Withdrawal in Seizure-Free Patients: What is New for the Pediatrician?

    The American Academy of Neurology (AAN) has recently updated its practise advisory on antiseizure medication withdrawal. The recommendations have...

    Arpita Gupta, Kunal Kumar in Indian Pediatrics
    Article 27 August 2022
  10. Antiseizure Medication Interactions A Clinical Guide

    This significantly revised fourth edition provides a practically orientated guide to interactions associated with antiseizure medications. It...

    Philip N. Patsalos
    Book 2022
  11. Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study

    Background

    Withdrawal of antiseizure medication treatment (ASM) can be considered after completion of antitumour treatment in glioma patients who no...

    Pim B. van der Meer, Linda Dirven, ... Johan A.F. Koekkoek in Journal of Neuro-Oncology
    Article Open access 27 September 2023
  12. Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database

    Background

    The association between antiseizure medications (ASMs) and suicidality remains controversial. Analyses of additional datasets are needed to...

    Emily E. Leppien, Bennett J. Doughty, ... Kenneth L. McCall in Clinical Drug Investigation
    Article 15 May 2023
  13. Sex Differences in Adverse Effects of Antiseizure Medications in Adults with Epilepsy: A Systematic Review

    Background

    Sex differences in epilepsy have been described in prevalence, seizure propensity and response to treatment. Therefore, taking into account...

    Loretta Giuliano, Vania Durante, ... Barbara Mostacci in CNS Drugs
    Article 30 April 2024
  14. The Effect of Levetiracetam Compared with Enzyme-Inducing Antiseizure Medications on Apixaban and Rivaroxaban Peak Plasma Concentrations

    Background and Objective

    Post-stroke epilepsy represents an important clinical challenge as it often requires both treatment with direct oral...

    Rachel Goldstein, Natalie Rabkin, ... Mordechai Muszkat in CNS Drugs
    Article Open access 23 March 2024
  15. Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis

    Objectives

    To compare the efficacy and safety of antiseizure medications (ASMs), both as monotherapies and adjunctive therapies, for idiopathic...

    Hongyuan Chu, **nyu Zhang, ... Xu Yang in Journal of Neurology
    Article Open access 28 June 2023
  16. Video-EEG monitoring as a valuable tool for antiseizure medication withdrawal in patients with epilepsy: implications for clinical practice and public health policies

    This letter to the editor discusses “the use of video-EEG monitoring to guide antiseizure medication (ASM) withdrawal in patients with epilepsy” [ 1 ]....

    Obed Okwoli Apochi in Neurological Research and Practice
    Article Open access 28 September 2023
  17. Efficacy and Safety of Five Broad-Spectrum Antiseizure Medications for Adjunctive Treatment of Refractory Epilepsy: A Systematic Review and Network Meta-analysis

    Background

    Overall, up to one-third of epilepsy patients have drug-resistant epilepsy. However, there was previously no meta-analysis to support the...

    Hecheng Wang, Haoran Wang, ... Yanshuo Han in CNS Drugs
    Article 17 August 2023
  18. Pilot study on the probability of drug-drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective

    Abstract Background

    There is little and controversial information about changes in plasma concentrations (PCs) or clinical events during...

    Federica Ranzato, Roberta Roberti, ... Gianfranco Di Gennaro in Neurological Sciences
    Article Open access 07 August 2023
  19. Brain tumor related epilepsy: pathophysiological approaches and rational management of antiseizure medication

    Background

    Brain tumor related epilepsy (BTRE) is a common complication of cerebral tumors and its incidence is highly dependent on the type of tumor,...

    Sabine Seidel, Tim Wehner, ... Wenke Grönheit in Neurological Research and Practice
    Article Open access 05 September 2022
Did you find what you were looking for? Share feedback.